Clinical Trial Update: Pharmacokinetic Study of Doxorubicin in Children With Cancer [Phase 2]

View source ↗

Summary

A completed Phase 2 pharmacokinetic study of doxorubicin in pediatric cancer patients, providing pharmacokinetic data for children with Wilms tumor, Neuroblasto…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Neuroblastoma
• Soft Tissue Sarcoma
• Wilms Tumor

Drugs mentioned

• Doxorubicin (doxorubicin)

Snippet

Sponsor: University Hospital Muenster | Conditions: Wilms Tumor, Neuroblastoma | Phase 2 | Status: COMPLETED